Karen Dawes, Director at Repligen, holds 87.37K shares in Repligen (Ticker: RGEN), holds 1.70K shares in Barinthus Biotherapeutics (Ticker: BRNS), holds 84.59K shares in Assertio Therapeutics (Ticker: ASRT). Most recently, Karen Dawes Bought ― shares of Repligen on Feb 28, 2024 for an estimated value of 194.62K.